Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Receives $24.25 Consensus Price Target from Brokerages

Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are currently covering the company, MarketBeat reports. One analyst has rated the stock with a sell rating and five have issued a buy rating on the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $24.25.

A number of research analysts recently commented on ANL shares. HC Wainwright raised their price objective on shares of Adlai Nortye from $16.00 to $20.00 and gave the company a “buy” rating in a research note on Monday, April 20th. JonesTrading initiated coverage on Adlai Nortye in a research note on Thursday, May 14th. They set a “buy” rating and a $22.00 price target for the company. Cantor Fitzgerald initiated coverage on Adlai Nortye in a research report on Monday. They set an “overweight” rating on the stock. Oppenheimer initiated coverage on Adlai Nortye in a research report on Thursday, May 28th. They set an “outperform” rating and a $32.00 price target on the stock. Finally, Wall Street Zen upgraded Adlai Nortye to a “hold” rating in a research report on Saturday, March 7th.

Adlai Nortye Stock Performance

Shares of NASDAQ ANL opened at $10.00 on Monday. The firm’s 50-day simple moving average is $12.25 and its 200 day simple moving average is $8.24. Adlai Nortye has a fifty-two week low of $0.88 and a fifty-two week high of $17.25.

Institutional Trading of Adlai Nortye

Large investors have recently added to or reduced their stakes in the business. SmartHarvest Portfolios LLC grew its holdings in shares of Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after acquiring an additional 1,279 shares during the last quarter. Renaissance Technologies LLC acquired a new position in shares of Adlai Nortye in the 1st quarter valued at $457,000. Affinity Asset Advisors LLC purchased a new position in Adlai Nortye in the 1st quarter worth about $1,140,000. Finally, ADAR1 Capital Management LLC purchased a new position in Adlai Nortye in the 1st quarter worth about $816,000. 35.21% of the stock is currently owned by institutional investors.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.